Send feedback

MORC2 p.Pro726Ala

c.2176C>G · rs2040627406 · VCV854241

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0604 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Charcot-Marie-Tooth disease axonal type 2Z

Computational evidence

Protein change
AlphaMissense0.0604likely benign
REVEL0.034moderately benign-leaning
SaProtLLR -6.90tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 6.7GERP 0.89, phastCons 1
Regional constrainto/e 1.02unconstrained · MANE · 1,093 bp · p 0.79 · regional, not allelic
Overall
CADD19.05PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00133% African / African-American · 1/75,038 alleles
Overall 0.000124% 2/1,614,160 alleles · very rare exomes 2/1,461,850 · genomes 0/152,310 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,508
African / African-Americangrpmax 0.00133% 75,038

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MORC2
Protein
p.Pro726Ala
Coding
c.2176C>G
MANE Select
NM_001303256
dbSNP
rs2040627406
Type
single nucleotide variant
Location
chr22:30934798 (GRCh38)
Gene constraint
LOEUF 0.3 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 78.37 · 9 PDB
Residue 726
the 'disordered' region
Full MORC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Charcot-Marie-Tooth disease axonal type 2Z — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Autosomal dominant Charcot-Marie-Tooth disease type 2Z (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood, Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/morc2-p-pro726ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown